Financials
- Market Capitalization 3.51 B
- Employee 601
- Founded 2015
- CEO -
- Website www.arcusbio.com
- Headquarter Delaware, United States
- FIGI BBG00DQD26W3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.81
ratio cours/chiffre d'affaires
9.87
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1587 | DNLI Denali Therapeutics Inc. - Common Stock | 22.96 USD | +1.37% | -12.33% | +3.80% | +41.99% | 3.64 B USD | ||
| 1597 | GPCR Structure Therapeutics Inc - American Depositary Shares | 48.49 USD | -4.15% | -11.74% | +13.53% | +81.34% | 3.45 B USD | ||
| 1608 | ADPT Adaptive Biotechnologies Corporation - Common Stock | 22.18 USD | +3.50% | +10.35% | +37.25% | +28.51% | 3.55 B USD | ||
| 1610 | ARQT Arcutis Biotherapeutics, Inc. - Common stock | 27.75 USD | +3.51% | -0.89% | +8.10% | +78.46% | 3.47 B USD |